Gyre Therapeutics, Inc. · NASDAQ:GYRE

Ye Weiguo sold 22,220 Gyre Therapeutics, Inc. shares (Form 4)

Traded May 20 to May 21, 2026 · Filed May 22, 2026

From May 20 to May 21, 2026, Ye Weiguo (Chief Operating Officer) sold 22,220 Gyre Therapeutics, Inc. shares at US$6.15 for US$137K, leaving 700,000 shares. Filed May 22, 2026 (Form 4).

Sold
22,220 shares
Price
US$6.15
Value
US$137K
Holding after
700,000 shares
Trading plan
No
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 20, 2026Common StockOption exercise9,400US$0.75709,400Direct
May 20, 2026Common StockSale9,400US$6.15700,000Direct
May 21, 2026Common StockOption exercise12,820US$0.75712,820Direct
May 21, 2026Common StockSale12,820US$6.15700,000Direct

Source

View original at SEC

Related